期刊
REPRODUCTIVE BIOMEDICINE ONLINE
卷 21, 期 4, 页码 572-580出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.rbmo.2010.04.032
关键词
ethnicity; infertility; insulin resistance; metabolic syndrome; polycystic ovary syndrome
资金
- Andromed
- Ardana
- Ferring
- Genovum
- Merck Serono
- Organon
- Pantharei Bioscience
- PregLem
- Schering
- Schering Plough
- Serono
- Wyeth
- Bayer Schering
- IBSA criteria
Polycystic ovary syndrome (PCOS) is strongly associated with metabolic abnormalities in Western women. However, data from other populations and geographical regions are scarce. This study evaluated cardiovascular and metabolic risk factors in Chinese infertile women diagnosed with PCOS using the 2003 Rotterdam consensus criteria. A total of 615 women representing the four PCOS phenotypes (oligo- or anovulation (AO) + hyperandrogenism (HA) + polycystic ovaries (PCO), AO + HA, AO + PCO and HA + PCO) underwent standardized metabolic screening including a 75 g oral glucose tolerance test. All groups presented with similar reproductive characteristics, with the only difference being a significantly higher Ferriman-Gallwey score for hirsutism (P = 0.01) in the subgroup characterized by HA + PCO. Overall, the prevalence of metabolic syndrome was 6.4%, with no difference among the four groups (range of 2.3-12.2%). Metabolic syndrome was associated with body mass index (P < 0.001), waist/hip ratio (P = 0.002), index of insulin resistance (P = 0.005) and fasting insulin (P = 0.009) in multivariate analysis. Compared with Caucasians and Chinese women in Westernized societies, mainland Chinese women with PCOS have a low risk of metabolic syndrome and its presence does not vary across the specific PCOS phenotypes. (C) 2010, Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据